Global 23-valent Pneumococcal Vaccine Market Research Report 2025(Status and Outlook)

March 2025 | 158 pages | ID: G51DF948FFE8EN
Bosson Research

Abstracts

Report Overview

23-valent Pneumococcal Vaccine is a type of vaccine that provides protection against infection caused by the bacterium Streptococcus pneumoniae. This vaccine contains 23 of the most common strains of the bacteria that can cause serious illnesses such as pneumonia, meningitis, and sepsis. It works by stimulating the body's immune system to produce antibodies against these specific strains, thereby reducing the risk of infection. The vaccine is typically recommended for adults over the age of 65, as well as younger individuals with certain medical conditions that put them at higher risk of pneumococcal disease. Overall, the 23-valent Pneumococcal Vaccine plays a crucial role in preventing potentially life-threatening infections caused by Streptococcus pneumoniae.

The market for 23-valent Pneumococcal Vaccine is driven by several key factors. One of the primary market drivers is the increasing awareness among healthcare providers and patients about the importance of vaccination in preventing infectious diseases. With growing emphasis on preventive healthcare measures, the demand for vaccines such as the 23-valent Pneumococcal Vaccine is expected to rise. Additionally, the aging population worldwide is contributing to the market growth, as older adults are more susceptible to pneumococcal infections and are therefore recommended to receive the vaccine. Furthermore, government initiatives and vaccination programs aimed at reducing the burden of pneumococcal disease are also fueling the market expansion. In addition to these factors, advancements in vaccine technology and the introduction of new and improved pneumococcal vaccines are likely to shape the market trends in the coming years.

This report provides a deep insight into the global 23-valent Pneumococcal Vaccine market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.

The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global 23-valent Pneumococcal Vaccine Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.

In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the 23-valent Pneumococcal Vaccine market in any manner.

Global 23-valent Pneumococcal Vaccine Market: Market Segmentation Analysis

The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.

Key Company

Merck

Sanofipasteur

CDIBP

Kexing Bio

Changsheng Bio-Technology

Huaan Science and Technology Innovation

Market Segmentation (by Type)

Single Dose Vial

Pre-filled Syringe

Market Segmentation (by Application)

Chronic Cardiovascular Disease

Chronic Lung Disease

Chronic Liver Disease

People Living with Hiv

Leukemia

Lymphoma

Multiple Myeloma

General Malignancy

Chronic Kidney Disease

Other

Geographic Segmentation

• North America (USA, Canada, Mexico)
• Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
• Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
• South America (Brazil, Argentina, Columbia, Rest of South America)
• The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:

• Industry drivers, restraints, and opportunities covered in the study
• Neutral perspective on the market performance
• Recent industry trends and developments
• Competitive landscape & strategies of key players
• Potential & niche segments and regions exhibiting promising growth covered
• Historical, current, and projected market size, in terms of value
• In-depth analysis of the 23-valent Pneumococcal Vaccine Market
• Overview of the regional outlook of the 23-valent Pneumococcal Vaccine Market:

Key Reasons to Buy this Report:

• Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
• This enables you to anticipate market changes to remain ahead of your competitors
• You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
• The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
• Provision of market value (USD Billion) data for each segment and sub-segment
• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
• The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
• Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
• Provides insight into the market through Value Chain
• Market dynamics scenario, along with growth opportunities of the market in the years to come
• 6-month post-sales analyst support

Customization of the Report

In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.

Chapter Outline

Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the 23-valent Pneumococcal Vaccine Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.

Chapter 12 is the main points and conclusions of the report.

Contents

1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE

1.1 Market Definition and Statistical Scope of 23-valent Pneumococcal Vaccine
1.2 Key Market Segments
  1.2.1 23-valent Pneumococcal Vaccine Segment by Type
  1.2.2 23-valent Pneumococcal Vaccine Segment by Application
1.3 Methodology & Sources of Information
  1.3.1 Research Methodology
  1.3.2 Research Process
  1.3.3 Market Breakdown and Data Triangulation
  1.3.4 Base Year
  1.3.5 Report Assumptions & Caveats

2 23-VALENT PNEUMOCOCCAL VACCINE MARKET OVERVIEW

2.1 Global Market Overview
  2.1.1 Global 23-valent Pneumococcal Vaccine Market Size (M USD) Estimates and Forecasts (2020-2033)
  2.1.2 Global 23-valent Pneumococcal Vaccine Sales Estimates and Forecasts (2020-2033)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region

3 23-VALENT PNEUMOCOCCAL VACCINE MARKET COMPETITIVE LANDSCAPE

3.1 Company Assessment Quadrant
3.2 Global 23-valent Pneumococcal Vaccine Product Life Cycle
3.3 Global 23-valent Pneumococcal Vaccine Sales by Manufacturers (2020-2025)
3.4 Global 23-valent Pneumococcal Vaccine Revenue Market Share by Manufacturers (2020-2025)
3.5 23-valent Pneumococcal Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global 23-valent Pneumococcal Vaccine Average Price by Manufacturers (2020-2025)
3.7 Manufacturers 23-valent Pneumococcal Vaccine Manufacturing Sites, Area Served, Product Type
3.8 23-valent Pneumococcal Vaccine Market Competitive Situation and Trends
  3.8.1 23-valent Pneumococcal Vaccine Market Concentration Rate
  3.8.2 Global 5 and 10 Largest 23-valent Pneumococcal Vaccine Players Market Share by Revenue
  3.8.3 Mergers & Acquisitions, Expansion

4 23-VALENT PNEUMOCOCCAL VACCINE INDUSTRY CHAIN ANALYSIS

4.1 23-valent Pneumococcal Vaccine Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis

5 THE DEVELOPMENT AND DYNAMICS OF 23-VALENT PNEUMOCOCCAL VACCINE MARKET

5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
  5.4.1 New Product Developments
  5.4.2 Mergers & Acquisitions
  5.4.3 Expansions
  5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
  5.5.1 Industry Policies Analysis
  5.5.2 Economic Environment Analysis
  5.5.3 Social Environment Analysis
  5.5.4 Technological Environment Analysis
5.6 Global 23-valent Pneumococcal Vaccine Market Porter's Five Forces Analysis
  5.6.1 Global Trade Frictions
  5.6.2 Global Trade Frictions and Their Impacts to 23-valent Pneumococcal Vaccine Market
5.7 ESG Ratings of Leading Companies

6 23-VALENT PNEUMOCOCCAL VACCINE MARKET SEGMENTATION BY TYPE

6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global 23-valent Pneumococcal Vaccine Sales Market Share by Type (2020-2025)
6.3 Global 23-valent Pneumococcal Vaccine Market Size Market Share by Type (2020-2025)
6.4 Global 23-valent Pneumococcal Vaccine Price by Type (2020-2025)

7 23-VALENT PNEUMOCOCCAL VACCINE MARKET SEGMENTATION BY APPLICATION

7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global 23-valent Pneumococcal Vaccine Market Sales by Application (2020-2025)
7.3 Global 23-valent Pneumococcal Vaccine Market Size (M USD) by Application (2020-2025)
7.4 Global 23-valent Pneumococcal Vaccine Sales Growth Rate by Application (2020-2025)

8 23-VALENT PNEUMOCOCCAL VACCINE MARKET SALES BY REGION

8.1 Global 23-valent Pneumococcal Vaccine Sales by Region
  8.1.1 Global 23-valent Pneumococcal Vaccine Sales by Region
  8.1.2 Global 23-valent Pneumococcal Vaccine Sales Market Share by Region
8.2 Global 23-valent Pneumococcal Vaccine Market Size by Region
  8.2.1 Global 23-valent Pneumococcal Vaccine Market Size by Region
  8.2.2 Global 23-valent Pneumococcal Vaccine Market Size Market Share by Region
8.3 North America
  8.3.1 North America 23-valent Pneumococcal Vaccine Sales by Country
  8.3.2 North America 23-valent Pneumococcal Vaccine Market Size by Country
  8.3.3 U.S. Market Overview
  8.3.4 Canada Market Overview
  8.3.5 Mexico Market Overview
8.4 Europe
  8.4.1 Europe 23-valent Pneumococcal Vaccine Sales by Country
  8.4.2 Europe 23-valent Pneumococcal Vaccine Market Size by Country
  8.4.3 Germany Market Overview
  8.4.4 France Market Overview
  8.4.5 U.K. Market Overview
  8.4.6 Italy Market Overview
  8.4.7 Spain Market Overview
8.5 Asia Pacific
  8.5.1 Asia Pacific 23-valent Pneumococcal Vaccine Sales by Region
  8.5.2 Asia Pacific 23-valent Pneumococcal Vaccine Market Size by Region
  8.5.3 China Market Overview
  8.5.4 Japan Market Overview
  8.5.5 South Korea Market Overview
  8.5.6 India Market Overview
  8.5.7 Southeast Asia Market Overview
8.6 South America
  8.6.1 South America 23-valent Pneumococcal Vaccine Sales by Country
  8.6.2 South America 23-valent Pneumococcal Vaccine Market Size by Country
  8.6.3 Brazil Market Overview
  8.6.4 Argentina Market Overview
  8.6.5 Columbia Market Overview
8.7 Middle East and Africa
  8.7.1 Middle East and Africa 23-valent Pneumococcal Vaccine Sales by Region
  8.7.2 Middle East and Africa 23-valent Pneumococcal Vaccine Market Size by Region
  8.7.3 Saudi Arabia Market Overview
  8.7.4 UAE Market Overview
  8.7.5 Egypt Market Overview
  8.7.6 Nigeria Market Overview
  8.7.7 South Africa Market Overview

9 23-VALENT PNEUMOCOCCAL VACCINE MARKET PRODUCTION BY REGION

9.1 Global Production of 23-valent Pneumococcal Vaccine by Region(2020-2025)
9.2 Global 23-valent Pneumococcal Vaccine Revenue Market Share by Region (2020-2025)
9.3 Global 23-valent Pneumococcal Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America 23-valent Pneumococcal Vaccine Production
  9.4.1 North America 23-valent Pneumococcal Vaccine Production Growth Rate (2020-2025)
  9.4.2 North America 23-valent Pneumococcal Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe 23-valent Pneumococcal Vaccine Production
  9.5.1 Europe 23-valent Pneumococcal Vaccine Production Growth Rate (2020-2025)
  9.5.2 Europe 23-valent Pneumococcal Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan 23-valent Pneumococcal Vaccine Production (2020-2025)
  9.6.1 Japan 23-valent Pneumococcal Vaccine Production Growth Rate (2020-2025)
  9.6.2 Japan 23-valent Pneumococcal Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China 23-valent Pneumococcal Vaccine Production (2020-2025)
  9.7.1 China 23-valent Pneumococcal Vaccine Production Growth Rate (2020-2025)
  9.7.2 China 23-valent Pneumococcal Vaccine Production, Revenue, Price and Gross Margin (2020-2025)

10 KEY COMPANIES PROFILE

10.1 Merck
  10.1.1 Merck Basic Information
  10.1.2 Merck 23-valent Pneumococcal Vaccine Product Overview
  10.1.3 Merck 23-valent Pneumococcal Vaccine Product Market Performance
  10.1.4 Merck Business Overview
  10.1.5 Merck SWOT Analysis
  10.1.6 Merck Recent Developments
10.2 Sanofipasteur
  10.2.1 Sanofipasteur Basic Information
  10.2.2 Sanofipasteur 23-valent Pneumococcal Vaccine Product Overview
  10.2.3 Sanofipasteur 23-valent Pneumococcal Vaccine Product Market Performance
  10.2.4 Sanofipasteur Business Overview
  10.2.5 Sanofipasteur SWOT Analysis
  10.2.6 Sanofipasteur Recent Developments
10.3 CDIBP
  10.3.1 CDIBP Basic Information
  10.3.2 CDIBP 23-valent Pneumococcal Vaccine Product Overview
  10.3.3 CDIBP 23-valent Pneumococcal Vaccine Product Market Performance
  10.3.4 CDIBP Business Overview
  10.3.5 CDIBP SWOT Analysis
  10.3.6 CDIBP Recent Developments
10.4 Kexing Bio
  10.4.1 Kexing Bio Basic Information
  10.4.2 Kexing Bio 23-valent Pneumococcal Vaccine Product Overview
  10.4.3 Kexing Bio 23-valent Pneumococcal Vaccine Product Market Performance
  10.4.4 Kexing Bio Business Overview
  10.4.5 Kexing Bio Recent Developments
10.5 Changsheng Bio-Technology
  10.5.1 Changsheng Bio-Technology Basic Information
  10.5.2 Changsheng Bio-Technology 23-valent Pneumococcal Vaccine Product Overview
  10.5.3 Changsheng Bio-Technology 23-valent Pneumococcal Vaccine Product Market Performance
  10.5.4 Changsheng Bio-Technology Business Overview
  10.5.5 Changsheng Bio-Technology Recent Developments
10.6 Huaan Science and Technology Innovation
  10.6.1 Huaan Science and Technology Innovation Basic Information
  10.6.2 Huaan Science and Technology Innovation 23-valent Pneumococcal Vaccine Product Overview
  10.6.3 Huaan Science and Technology Innovation 23-valent Pneumococcal Vaccine Product Market Performance
  10.6.4 Huaan Science and Technology Innovation Business Overview
  10.6.5 Huaan Science and Technology Innovation Recent Developments

11 23-VALENT PNEUMOCOCCAL VACCINE MARKET FORECAST BY REGION

11.1 Global 23-valent Pneumococcal Vaccine Market Size Forecast
11.2 Global 23-valent Pneumococcal Vaccine Market Forecast by Region
  11.2.1 North America Market Size Forecast by Country
  11.2.2 Europe 23-valent Pneumococcal Vaccine Market Size Forecast by Country
  11.2.3 Asia Pacific 23-valent Pneumococcal Vaccine Market Size Forecast by Region
  11.2.4 South America 23-valent Pneumococcal Vaccine Market Size Forecast by Country
  11.2.5 Middle East and Africa Forecasted Sales of 23-valent Pneumococcal Vaccine by Country

12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2033)

12.1 Global 23-valent Pneumococcal Vaccine Market Forecast by Type (2026-2033)
  12.1.1 Global Forecasted Sales of 23-valent Pneumococcal Vaccine by Type (2026-2033)
  12.1.2 Global 23-valent Pneumococcal Vaccine Market Size Forecast by Type (2026-2033)
  12.1.3 Global Forecasted Price of 23-valent Pneumococcal Vaccine by Type (2026-2033)
12.2 Global 23-valent Pneumococcal Vaccine Market Forecast by Application (2026-2033)
  12.2.1 Global 23-valent Pneumococcal Vaccine Sales (K MT) Forecast by Application
  12.2.2 Global 23-valent Pneumococcal Vaccine Market Size (M USD) Forecast by Application (2026-2033)

13 CONCLUSION AND KEY FINDINGS
List of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. 23-valent Pneumococcal Vaccine Market Size Comparison by Region (M USD)
Table 5. Global 23-valent Pneumococcal Vaccine Sales (K MT) by Manufacturers (2020-2025)
Table 6. Global 23-valent Pneumococcal Vaccine Sales Market Share by Manufacturers (2020-2025)
Table 7. Global 23-valent Pneumococcal Vaccine Revenue (M USD) by Manufacturers (2020-2025)
Table 8. Global 23-valent Pneumococcal Vaccine Revenue Share by Manufacturers (2020-2025)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in 23-valent Pneumococcal Vaccine as of 2024)
Table 10. Global Market 23-valent Pneumococcal Vaccine Average Price (USD/MT) of Key Manufacturers (2020-2025)
Table 11. Manufacturers 23-valent Pneumococcal Vaccine Manufacturing Sites and Area Served
Table 12. Manufacturers 23-valent Pneumococcal Vaccine Product Type
Table 13. Global 23-valent Pneumococcal Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Market Overview of Key Raw Materials
Table 16. Midstream Market Analysis
Table 17. Downstream Customer Analysis
Table 18. Key Development Trends
Table 19. Driving Factors
Table 20. 23-valent Pneumococcal Vaccine Market Challenges
Table 21. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 22. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 23. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 24. Global 23-valent Pneumococcal Vaccine Sales by Type (K MT)
Table 25. Global 23-valent Pneumococcal Vaccine Market Size by Type (M USD)
Table 26. Global 23-valent Pneumococcal Vaccine Sales (K MT) by Type (2020-2025)
Table 27. Global 23-valent Pneumococcal Vaccine Sales Market Share by Type (2020-2025)
Table 28. Global 23-valent Pneumococcal Vaccine Market Size (M USD) by Type (2020-2025)
Table 29. Global 23-valent Pneumococcal Vaccine Market Size Share by Type (2020-2025)
Table 30. Global 23-valent Pneumococcal Vaccine Price (USD/MT) by Type (2020-2025)
Table 31. Global 23-valent Pneumococcal Vaccine Sales (K MT) by Application
Table 32. Global 23-valent Pneumococcal Vaccine Market Size by Application
Table 33. Global 23-valent Pneumococcal Vaccine Sales by Application (2020-2025) & (K MT)
Table 34. Global 23-valent Pneumococcal Vaccine Sales Market Share by Application (2020-2025)
Table 35. Global 23-valent Pneumococcal Vaccine Market Size by Application (2020-2025) & (M USD)
Table 36. Global 23-valent Pneumococcal Vaccine Market Share by Application (2020-2025)
Table 37. Global 23-valent Pneumococcal Vaccine Sales Growth Rate by Application (2020-2025)
Table 38. Global 23-valent Pneumococcal Vaccine Sales by Region (2020-2025) & (K MT)
Table 39. Global 23-valent Pneumococcal Vaccine Sales Market Share by Region (2020-2025)
Table 40. Global 23-valent Pneumococcal Vaccine Market Size by Region (2020-2025) & (M USD)
Table 41. Global 23-valent Pneumococcal Vaccine Market Size Market Share by Region (2020-2025)
Table 42. North America 23-valent Pneumococcal Vaccine Sales by Country (2020-2025) & (K MT)
Table 43. North America 23-valent Pneumococcal Vaccine Market Size by Country (2020-2025) & (M USD)
Table 44. Europe 23-valent Pneumococcal Vaccine Sales by Country (2020-2025) & (K MT)
Table 45. Europe 23-valent Pneumococcal Vaccine Market Size by Country (2020-2025) & (M USD)
Table 46. Asia Pacific 23-valent Pneumococcal Vaccine Sales by Region (2020-2025) & (K MT)
Table 47. Asia Pacific 23-valent Pneumococcal Vaccine Market Size by Region (2020-2025) & (M USD)
Table 48. South America 23-valent Pneumococcal Vaccine Sales by Country (2020-2025) & (K MT)
Table 49. South America 23-valent Pneumococcal Vaccine Market Size by Country (2020-2025) & (M USD)
Table 50. Middle East and Africa 23-valent Pneumococcal Vaccine Sales by Region (2020-2025) & (K MT)
Table 51. Middle East and Africa 23-valent Pneumococcal Vaccine Market Size by Region (2020-2025) & (M USD)
Table 52. Global 23-valent Pneumococcal Vaccine Production (K MT) by Region(2020-2025)
Table 53. Global 23-valent Pneumococcal Vaccine Revenue (US$ Million) by Region (2020-2025)
Table 54. Global 23-valent Pneumococcal Vaccine Revenue Market Share by Region (2020-2025)
Table 55. Global 23-valent Pneumococcal Vaccine Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 56. North America 23-valent Pneumococcal Vaccine Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 57. Europe 23-valent Pneumococcal Vaccine Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 58. Japan 23-valent Pneumococcal Vaccine Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 59. China 23-valent Pneumococcal Vaccine Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 60. Merck Basic Information
Table 61. Merck 23-valent Pneumococcal Vaccine Product Overview
Table 62. Merck 23-valent Pneumococcal Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 63. Merck Business Overview
Table 64. Merck SWOT Analysis
Table 65. Merck Recent Developments
Table 66. Sanofipasteur Basic Information
Table 67. Sanofipasteur 23-valent Pneumococcal Vaccine Product Overview
Table 68. Sanofipasteur 23-valent Pneumococcal Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 69. Sanofipasteur Business Overview
Table 70. Sanofipasteur SWOT Analysis
Table 71. Sanofipasteur Recent Developments
Table 72. CDIBP Basic Information
Table 73. CDIBP 23-valent Pneumococcal Vaccine Product Overview
Table 74. CDIBP 23-valent Pneumococcal Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 75. CDIBP Business Overview
Table 76. CDIBP SWOT Analysis
Table 77. CDIBP Recent Developments
Table 78. Kexing Bio Basic Information
Table 79. Kexing Bio 23-valent Pneumococcal Vaccine Product Overview
Table 80. Kexing Bio 23-valent Pneumococcal Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 81. Kexing Bio Business Overview
Table 82. Kexing Bio Recent Developments
Table 83. Changsheng Bio-Technology Basic Information
Table 84. Changsheng Bio-Technology 23-valent Pneumococcal Vaccine Product Overview
Table 85. Changsheng Bio-Technology 23-valent Pneumococcal Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 86. Changsheng Bio-Technology Business Overview
Table 87. Changsheng Bio-Technology Recent Developments
Table 88. Huaan Science and Technology Innovation Basic Information
Table 89. Huaan Science and Technology Innovation 23-valent Pneumococcal Vaccine Product Overview
Table 90. Huaan Science and Technology Innovation 23-valent Pneumococcal Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 91. Huaan Science and Technology Innovation Business Overview
Table 92. Huaan Science and Technology Innovation Recent Developments
Table 93. Global 23-valent Pneumococcal Vaccine Sales Forecast by Region (2026-2033) & (K MT)
Table 94. Global 23-valent Pneumococcal Vaccine Market Size Forecast by Region (2026-2033) & (M USD)
Table 95. North America 23-valent Pneumococcal Vaccine Sales Forecast by Country (2026-2033) & (K MT)
Table 96. North America 23-valent Pneumococcal Vaccine Market Size Forecast by Country (2026-2033) & (M USD)
Table 97. Europe 23-valent Pneumococcal Vaccine Sales Forecast by Country (2026-2033) & (K MT)
Table 98. Europe 23-valent Pneumococcal Vaccine Market Size Forecast by Country (2026-2033) & (M USD)
Table 99. Asia Pacific 23-valent Pneumococcal Vaccine Sales Forecast by Region (2026-2033) & (K MT)
Table 100. Asia Pacific 23-valent Pneumococcal Vaccine Market Size Forecast by Region (2026-2033) & (M USD)
Table 101. South America 23-valent Pneumococcal Vaccine Sales Forecast by Country (2026-2033) & (K MT)
Table 102. South America 23-valent Pneumococcal Vaccine Market Size Forecast by Country (2026-2033) & (M USD)
Table 103. Middle East and Africa 23-valent Pneumococcal Vaccine Sales Forecast by Country (2026-2033) & (Units)
Table 104. Middle East and Africa 23-valent Pneumococcal Vaccine Market Size Forecast by Country (2026-2033) & (M USD)
Table 105. Global 23-valent Pneumococcal Vaccine Sales Forecast by Type (2026-2033) & (K MT)
Table 106. Global 23-valent Pneumococcal Vaccine Market Size Forecast by Type (2026-2033) & (M USD)
Table 107. Global 23-valent Pneumococcal Vaccine Price Forecast by Type (2026-2033) & (USD/MT)
Table 108. Global 23-valent Pneumococcal Vaccine Sales (K MT) Forecast by Application (2026-2033)
Table 109. Global 23-valent Pneumococcal Vaccine Market Size Forecast by Application (2026-2033) & (M USD)
List of Figures
Figure 1. Product Picture of 23-valent Pneumococcal Vaccine
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global 23-valent Pneumococcal Vaccine Market Size (M USD), 2024-2033
Figure 5. Global 23-valent Pneumococcal Vaccine Market Size (M USD) (2020-2033)
Figure 6. Global 23-valent Pneumococcal Vaccine Sales (K MT) & (2020-2033)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. 23-valent Pneumococcal Vaccine Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global 23-valent Pneumococcal Vaccine Product Life Cycle
Figure 13. 23-valent Pneumococcal Vaccine Sales Share by Manufacturers in 2024
Figure 14. Global 23-valent Pneumococcal Vaccine Revenue Share by Manufacturers in 2024
Figure 15. 23-valent Pneumococcal Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024
Figure 16. Global Market 23-valent Pneumococcal Vaccine Average Price (USD/MT) of Key Manufacturers in 2024
Figure 17. The Global 5 and 10 Largest Players: Market Share by 23-valent Pneumococcal Vaccine Revenue in 2024
Figure 18. Industry Chain Map of 23-valent Pneumococcal Vaccine
Figure 19. Global 23-valent Pneumococcal Vaccine Market PEST Analysis
Figure 20. Global 23-valent Pneumococcal Vaccine Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global 23-valent Pneumococcal Vaccine Market Share by Type
Figure 27. Sales Market Share of 23-valent Pneumococcal Vaccine by Type (2020-2025)
Figure 28. Sales Market Share of 23-valent Pneumococcal Vaccine by Type in 2024
Figure 29. Market Size Share of 23-valent Pneumococcal Vaccine by Type (2020-2025)
Figure 30. Market Size Share of 23-valent Pneumococcal Vaccine by Type in 2024
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global 23-valent Pneumococcal Vaccine Market Share by Application
Figure 33. Global 23-valent Pneumococcal Vaccine Sales Market Share by Application (2020-2025)
Figure 34. Global 23-valent Pneumococcal Vaccine Sales Market Share by Application in 2024
Figure 35. Global 23-valent Pneumococcal Vaccine Market Share by Application (2020-2025)
Figure 36. Global 23-valent Pneumococcal Vaccine Market Share by Application in 2024
Figure 37. Global 23-valent Pneumococcal Vaccine Sales Growth Rate by Application (2020-2025)
Figure 38. Global 23-valent Pneumococcal Vaccine Sales Market Share by Region (2020-2025)
Figure 39. Global 23-valent Pneumococcal Vaccine Market Size Market Share by Region (2020-2025)
Figure 40. North America 23-valent Pneumococcal Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America 23-valent Pneumococcal Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America 23-valent Pneumococcal Vaccine Sales Market Share by Country in 2024
Figure 43. North America 23-valent Pneumococcal Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America 23-valent Pneumococcal Vaccine Market Size Market Share by Country in 2024
Figure 45. U.S. 23-valent Pneumococcal Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. 23-valent Pneumococcal Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada 23-valent Pneumococcal Vaccine Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada 23-valent Pneumococcal Vaccine Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico 23-valent Pneumococcal Vaccine Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico 23-valent Pneumococcal Vaccine Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe 23-valent Pneumococcal Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe 23-valent Pneumococcal Vaccine Sales Market Share by Country in 2024
Figure 53. Europe 23-valent Pneumococcal Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe 23-valent Pneumococcal Vaccine Market Size Market Share by Country in 2024
Figure 55. Germany 23-valent Pneumococcal Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany 23-valent Pneumococcal Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France 23-valent Pneumococcal Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France 23-valent Pneumococcal Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. 23-valent Pneumococcal Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. 23-valent Pneumococcal Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy 23-valent Pneumococcal Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy 23-valent Pneumococcal Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain 23-valent Pneumococcal Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain 23-valent Pneumococcal Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific 23-valent Pneumococcal Vaccine Sales and Growth Rate (K MT)
Figure 66. Asia Pacific 23-valent Pneumococcal Vaccine Sales Market Share by Region in 2024
Figure 67. Asia Pacific 23-valent Pneumococcal Vaccine Market Size Market Share by Region in 2024
Figure 68. China 23-valent Pneumococcal Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China 23-valent Pneumococcal Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan 23-valent Pneumococcal Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan 23-valent Pneumococcal Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea 23-valent Pneumococcal Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea 23-valent Pneumococcal Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India 23-valent Pneumococcal Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India 23-valent Pneumococcal Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia 23-valent Pneumococcal Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia 23-valent Pneumococcal Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America 23-valent Pneumococcal Vaccine Sales and Growth Rate (K MT)
Figure 79. South America 23-valent Pneumococcal Vaccine Sales Market Share by Country in 2024
Figure 80. South America 23-valent Pneumococcal Vaccine Market Size and Growth Rate (M USD)
Figure 81. South America 23-valent Pneumococcal Vaccine Market Size Market Share by Country in 2024
Figure 82. Brazil 23-valent Pneumococcal Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil 23-valent Pneumococcal Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina 23-valent Pneumococcal Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina 23-valent Pneumococcal Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia 23-valent Pneumococcal Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia 23-valent Pneumococcal Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa 23-valent Pneumococcal Vaccine Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa 23-valent Pneumococcal Vaccine Sales Market Share by Region in 2024
Figure 90. Middle East and Africa 23-valent Pneumococcal Vaccine Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa 23-valent Pneumococcal Vaccine Market Size Market Share by Region in 2024
Figure 92. Saudi Arabia 23-valent Pneumococcal Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia 23-valent Pneumococcal Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE 23-valent Pneumococcal Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE 23-valent Pneumococcal Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt 23-valent Pneumococcal Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt 23-valent Pneumococcal Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria 23-valent Pneumococcal Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria 23-valent Pneumococcal Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa 23-valent Pneumococcal Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa 23-valent Pneumococcal Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global 23-valent Pneumococcal Vaccine Production Market Share by Region (2020-2025)
Figure 103. North America 23-valent Pneumococcal Vaccine Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe 23-valent Pneumococcal Vaccine Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan 23-valent Pneumococcal Vaccine Production (K MT) Growth Rate (2020-2025)
Figure 106. China 23-valent Pneumococcal Vaccine Production (K MT) Growth Rate (2020-2025)
Figure 107. Global 23-valent Pneumococcal Vaccine Sales Forecast by Volume (2020-2033) & (K MT)
Figure 108. Global 23-valent Pneumococcal Vaccine Market Size Forecast by Value (2020-2033) & (M USD)
Figure 109. Global 23-valent Pneumococcal Vaccine Sales Market Share Forecast by Type (2026-2033)
Figure 110. Global 23-valent Pneumococcal Vaccine Market Share Forecast by Type (2026-2033)
Figure 111. Global 23-valent Pneumococcal Vaccine Sales Forecast by Application (2026-2033)
Figure 112. Global 23-valent Pneumococcal Vaccine Market Share Forecast by Application (2026-2033)